Mutations in SDHC cause autosomal dominant paraganglioma, type 3
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Nonchromaffin paragangliomas (PGLs) are usually benign, neural-crest-derived, slow-growing tumours of parasympathetic ganglia. Between 10% and 50% of cases are familial and are transmitted as autosomal dominant traits with incomplete and age-dependent penetrance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“germline mutations in the B, C and D subunits of SDH predispose individuals to hereditary paragangliomatosis with phaeochromocytomas (HPGL) (2 -6)”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [4]
In the citing paper
“In 2008, mutation of SDH was discovered in cancers such as paraganglioma and pheochromocytoma cells124. Later, similar observations were made in gastrointestinal tumors, neuroblastomas, renal tumors, thyroid tumors, and testicular tumors125,126.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [126]
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
PROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE
Rosman, J., Ter Wee, P., Meijer Truus, S., Piers-Becht, P. M., Sluiter, W., & Donker, A. M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90818-3 · Cited by 555
GENOMIC IMPRINTING IN HEREDITARY GLOMUS TUMOURS: EVIDENCE FOR NEW GENETIC THEORY
Van Der Mey, A. L., Maaswinkel-Mooy, P., Cornelisse, C., Schmidt, P., & Van De Kamp, J. P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91908-9 · Cited by 305
Familial carotid body tumors: Case report and epidemiologic review
Grufferman, S., Gillman, M. W., Pasternak, L. R., Peterson, C. L., & Young, W. G. (1980) · Cancer · doi:10.1002/1097-0142(19801101)46:9<2116::aid-cncr2820460934>3.0.co;2-s · Cited by 240
Heutink, P., Mey, A. G. L. V. D., Sandkuijl, L. A., Gils, A. P. G. V., Bardoel, A., Breedveld, G. J., Vliet, M. V., Ommen, G.-J. B. V., Cornelisse, C. J., Oostra, B. A., et al. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.1.7 · Cited by 214
Mariman, E. C. M., van Beersum, S. E. C., Cremers, C. W. R. J., Struycken, P., & Ropers, H. (1995) · Human Genetics · doi:10.1007/bf00225075 · Cited by 136
Hirawake, H., Taniwaki, M., Tamura, A., Kojima, S., & Kita, K. (1997) · Cytogenetic and Genome Research · doi:10.1159/000134700 · Cited by 62
Repositioning the hereditary paraganglioma critical region on chromosome band 11q23
Baysal, B. E., van Schothorst, E. M., Farr, J. E., Grashoff, P., Myssiorek, D. J., Rubinstein, W. S., Taschner, P. E. M., Cornelisse, C. J., Devlin, B., Devilee, P., et al. (1999) · Human Genetics · doi:10.1007/s004390050939 · Cited by 58
PGL3 , a third, not maternally imprinted locus in autosomal dominant paraganglioma
Niemann, S., Steinberger, D., & Müller, U. (1999) · Neurogenetics · doi:10.1007/s100480050078 · Cited by 54
Self-citation
Cited by
Items 201–300 of 938
The multifaceted contribution of α-ketoglutarate to tumor progression: An opportunity to exploit?
Abla, H., Sollazzo, M., Gasparre, G., Iommarini, L., & Porcelli, A. M. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.031 · Cited by 102
Wong, L.-J. C., Lueth, M., Li, X.-N., Lau, C. C., & Vogel, H. S. (2003) · PubMed · Cited by 101
Pollard, P., Wortham, N., Barclay, E., Alam, A., Elia, G., Manek, S., Poulsom, R., & Tomlinson, I. (2005) · The Journal of Pathology · doi:10.1002/path.1686 · Cited by 100
Luchetti, A., Walsh, D. M., Rodger, F., Clark, G. R., Martin, T., Irving, R. M., Sanna, M., Yao, M., Robledo, M., Neumann, H. P. H., et al. (2015) · International Journal of Endocrinology · doi:10.1155/2015/138573 · Cited by 100
Hoekstra, A. S., de Graaff, M. A., Briaire-de Bruijn, I. H., Ras, C., Seifar, R. M., van Minderhout, I., Cornelisse, C. J., Hogendoorn, P. C. W., Breuning, M. H., Suijker, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6091 · Cited by 99
“Germline mutations in SDHA [1], SDHB [2], SDHC [3], SDHD [4], and SDHAF2 [5] cause paraganglioma/pheochromocytoma (PGL/PCC).”
BackgroundAerobic glycolysis: a novel target in kidney cancer
Shuch, B. M., Linehan, W. M., & Srinivasan, R. (2013) · Expert Review of Anticancer Therapy · doi:10.1586/era.13.57 · Cited by 99
68Ga-DOTA-TATE PET vs. 123I-MIBG in Identifying Malignant Neural Crest Tumours
Naji, M., Zhao, C., Welsh, S. J., Meades, R., Win, Z., Ferrarese, A., Tan, T., Rubello, D., & AL-NAHHAS, A. M. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0396-8 · Cited by 98
Genetically-defined metabolic reprogramming in cancer
Mullen, A. R., & DeBerardinis, R. J. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.06.009 · Cited by 86
Metabolic adaptations in prostate cancer
Pujana-Vaquerizo, M., Bozal‐Basterra, L., & Carracedo, A. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02762-z · Cited by 98
Genetics of hereditary head and neck paragangliomas
Boedeker, C. C., Hensen, E. F., Neumann, H. P. H., Maier, W., van Nederveen, F. H., Suarez, C. M., Kunst, H. P. M., Rodrigo, J. P., Takes, R. P., Pellitteri, P. K., et al. (2013) · Head & Neck · doi:10.1002/hed.23436 · Cited by 97
“Until October 2005, only 4 patients with SDHC mutations had been described.(19,58) 60 Most authors concluded that SDHC mutations must be exceedingly rare and therefore, patients with HNPGs were not routinely tested for mutations of the SDHC gene.”
BackgroundDisorders of mitochondrial function
Debray, F., Lambert, M. A., & Mitchell, G. A. (2008) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328306ebb6 · Cited by 96
Rationale for Anti-angiogenic Therapy in Pheochromocytoma and Paraganglioma
Favier, J., Igaz, P., Burnichon, N., Amar, L., Libé, R., Badoual, C., Tissier, F., Bertherat, J. Y., Plouin, P., Jeunemaître, X., et al. (2011) · Endocrine Pathology · doi:10.1007/s12022-011-9189-0 · Cited by 95
Douwes Dekker, P., Hogendoorn, P., Kuipers‐Dijkshoorn, N., Prins, F., van Duinen, S., Taschner, P., van der Mey, A., & Cornelisse, C. (2003) · The Journal of Pathology · doi:10.1002/path.1461 · Cited by 94
“Recent studies have established that the genomic defect in head and neck paragangliomas involves mutations in the genes encoding subunits of complex II of the (mitochondrial) respiratory chain [1,4,5].”
BackgroundSrirangalingam, U., Walker, L., Khoo, B. C. E., MacDonald, F., Gardner, D. S.-L., Wilkin, T. J., Skelly, R. H., George, E., Spooner, D. A., Monson, J. P., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03274.x · Cited by 93
Jackson, C. B., Nuoffer, J., Hahn, D., Prokisch, H., Haberberger, B., Gautschi, M., Häberli, A., Gallati, S., & Schaller, A. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101932 · Cited by 93
Co-regulation of mitochondrial respiration by proline dehydrogenase/oxidase and succinate
Hancock, C. N., Liu, W., Alvord, W. G., & Phang, J. M. (2015) · Amino Acids · doi:10.1007/s00726-015-2134-7 · Cited by 92
“Mutations in SDHB, SDHC, and SDHD have been found in hereditary paraganglioma (Baysal et al. 2000; Niemann and Muller 2000; Astuti et al. 2001), gastrointestinal stromal tumors (GISTs) (Pasini et al.”
BackgroundGenetics and molecular pathogenesis of pheochromocytoma and paraganglioma
Galan, S., & Kann, P. H. (2012) · Clinical Endocrinology · doi:10.1111/cen.12071 · Cited by 92
Rare insights into cancer biology
Adam, J., Yang, M., Soga, T., & Pollard, P. J. (2013) · Oncogene · doi:10.1038/onc.2013.222 · Cited by 92
Physiological consequences of complex II inhibition for aging, disease, and the mKATP channel
Wojtovich, A. P., Smith, C. O., Haynes, C. M., Nehrke, K. W., & Brookes, P. S. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.12.007 · Cited by 83
“or nonsense mutations typically produce slow growing or benign (SDHC [8] and SDHD [9]) or highly aggressive (SDHB [10]) tumors of the carotid body, classified as hereditary paragangliomas or pheochromocytomas.”
BackgroundAdvances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research
Ooi, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.016 · Cited by 90
Paragangliomas/Pheochromocytomas: Clinically Oriented Genetic Testing
Martins, R., & Bugalho, M. J. (2014) · International Journal of Endocrinology · doi:10.1155/2014/794187 · Cited by 90
Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma
Hensen, E. F., & Bayley, J. (2010) · Familial Cancer · doi:10.1007/s10689-010-9402-1 · Cited by 90
“SDHC was the second SDH subunit gene identified as a cause of paragangliomas [11].”
BackgroundModern Nuclear Imaging for Paragangliomas: Beyond SPECT
Taïeb, D., Neumann, H. P. H., Rubello, D., AL-NAHHAS, A. M., Guillet, B. A., & Hindié, E. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.098152 · Cited by 90
“Consequently, paraganglioma types 3 and 4 have been described as associated with germline mutations of the genes SDHC and SDHB, respectively (7,8).”
BackgroundVon Hippel-Lindau disease and endocrine tumour susceptibility
Woodward, E. R., & Maher, E. R. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.00683 · Cited by 87
“Germline mutations in three (SDHB, SDHC and SDHD) of the four SDH subunits have been associated with inherited phaeochromocytoma, but germline mutations in SDHC are rare (Niemann & Muller 2000).”
BackgroundMcWhinney, S. R., Pilarski, R. T., Forrester, S. R., Schneider, M. C., Sarquis, M. M., Dias, E. P., & Eng, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0769 · Cited by 89
The genomic landscape of phaeochromocytoma
Flynn, A., Benn, D. E., Clifton-Bligh, R. J., Robinson, B. G., Trainer, A. H., James, P. A., Hogg, A., Waldeck, K., George, J., Li, J., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4503 · Cited by 89
“Alternatively, mutations in metabolic Kreb-cycle members, including the four succinate dehydrogenase subunits (SDHA-D), SDH-flavination factor (SDHAF2) and fumarate hydratase (FH) lead to accumulation of intracellular metabolites that inhibit the function of dioxygenase proteins such as PHD2[11-17].”
BackgroundVan Coster, R., Seneca, S., Smet, J., Van Hecke, R., Gerlo, E., Devreese, B., Van Beeumen, J., Leroy, J. G., De Meirleir, L., & Lissens, W. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.10202 · Cited by 83
Nannini, M., Biasco, G., Astolfi, A., & Pantaleo, M. A. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101695 · Cited by 88
Clinical and molecular progress in hereditary paraganglioma: Figure 1
Baysal, B. E. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.058560 · Cited by 86
“Subsequently, mutations were identified in the SDHC and SDHB subunits by direct candidate gene analyses.(4) 5 The SDH mutations predisposing to PGL are heterozygous, transmitted in germ line and cause loss of function.”
BackgroundParagangliomas and paraganglioma syndromes
Boedeker, C. C. (2011) · PubMed Central · doi:10.3205/cto000076 · Cited by 86
“Nieman et Müller first identified an SDHC mutation as the underlying cause of PGL 3 [154].”
BackgroundInfluentialBadenhop, R. F., Jansen, J. C., Fagan, P. A., Lord, R. S. A., Wang, Z. G., Foster, W. J., & Schofield, P. R. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.011551 · Cited by 86
“26 To date mutations of the SDHC gene are restricted to the report of a single pedigree, 13 and the contribution of the SDHC gene to the aetiology of PGL remains unclear.”
BackgroundManagement of head and neck paragangliomas: Review of 120 patients
Papaspyrou, K., Mann, W. J., & Amedee, R. G. (2008) · Head & Neck · doi:10.1002/hed.20967 · Cited by 86
Fishbein, L. M., Orlowski, R. Z., & Cohen, D. L. (2013) · Journal of Clinical Hypertension · doi:10.1111/jch.12084 · Cited by 86
The Tumor Suppressor cybL, a Component of the Respiratory Chain, Mediates Apoptosis Induction
Albayrak, T., Scherhammer, V., Schoenfeld, N., Braziulis, E., Mund, T., Bauer, M. K. A., Scheffler, I. E., & Grimm, S. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-10-0631 · Cited by 75
“Most importantly, mutations in cybS and cybL have recently been shown to be responsible for hereditary paragangliomas (Baysal et al., 2000; Niemann and Muller, 2000).”
BackgroundInfluentialLendvai, N., Pawlosky, R., Bullova, P., Eisenhofer, G., Patocs, A., Veech, R. L., & Pacak, K. (2014) · Endocrinology · doi:10.1210/en.2013-1549 · Cited by 76
Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: A possible hot spot?
Cascón, A., Montero‐Conde, C., Ruiz‐Llorente, S., Mercadillo, F., Letón, R., Rodríguez‐Antona, C., Martínez‐Delgado, B., Delgado, M., Díez, A., Rovira, A., et al. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20283 · Cited by 75
“On the other hand, hereditary PGLs are mainly associated with germ-line mutations in the succinate dehydrogenase (SDH) subunits: SDHB, the iron sulfur protein, associated with PGL type 4; SDHD, the small integral membrane protein, with PGL type 1; and SDHC, the remaining integral protein of the complex, with PGL type…”
BackgroundAn Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma
Baysal, B. E., Willett-Brozick, J. E., Filho, P. A. A., Lawrence, E. C., Myers, E. N., & Ferrell, R. E. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.019224 · Cited by 78
BRCA1 Induces Major Energetic Metabolism Reprogramming in Breast Cancer Cells
Privat, M., Radosevic‐Robin, N., Aubel, C., Cayre, A., Penault-Llorca, F. M., Marceau, G., Sapin, V., Bignon, Y., & Morvan, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102438 · Cited by 84
“Recently, new tumor suppressor genes encoding proteins involved in metabolic pathways have been discovered, notably those involved in citrate metabolism [11], including sdha/c (succinate dehydrogenase) in paragangliomas [12,13,14,15], and idh1/2 (isocitrate dehydrogenase) in low and high grade gliomas [16,17].”
BackgroundCurrent assessment and management of glomus tumors
Semaan, M. T., & Megerian, C. A. (2008) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0b013e32830c4595 · Cited by 84
Etiopathogenesis and clinical presentation of carotid body tumors
Baysal, B. E., & Myers, E. N. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10200 · Cited by 83
The Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity
Scagliola, A., Mainini, F., & Cardaci, S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7974 · Cited by 84
“…genes were originally identified in patients with hereditary pheochromocytomas (PHEO) and paragangliomas (PGG), rare neuroendocrine neoplasms of the chromaffin tissue of the adrenal medulla, or arising from the parasympathetic tissue of the head and neck paraganglia, respectively (5, 12, 13, 78, 80).”
Sweeney, A. D., Carlson, M. L., Wanna, G. B., & Bennett, M. L. (2015) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2014.12.004 · Cited by 83
Goffrini, P., Ercolino, T., Panizza, E., Giache, V., Cavone, L., Chiarugi, A., Dima, V., Ferrero, I., & Mannelli, M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp102 · Cited by 69
GEP- NETS UPDATE: Genetics of neuroendocrine tumors
Crona, J., & Skogseid, B. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0972 · Cited by 83
Mitochondria and reactive oxygen species in renal cancer
Hervouet, É., Simonnet, H., & Godinot, C. (2007) · Biochimie · doi:10.1016/j.biochi.2007.03.010 · Cited by 83
Milunsky, J. M., Maher, T. A., Michels, V. V., & Milunsky, A. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1270 · Cited by 77
Respiratory chain complex II as general sensor for apoptosis
Grimm, S. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.09.009 · Cited by 82
Rethinking pheochromocytomas and paragangliomas from a genomic perspective
Castro‐Vega, L. J., Lussey‐Lepoutre, C., Gimenez‐Roqueplo, A., & Favier, J. (2015) · Oncogene · doi:10.1038/onc.2015.172 · Cited by 82
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients
Piccini, V., Rapizzi, E., Bacca, A., Trapani, G. D., Pulli, R., Giaché, V., Zampetti, B., Cordisco, E. L., Canu, L., Corsini, E., et al. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0369 · Cited by 82
Neumann, H. P. H., Young, W. F., Krauß, T., Bayley, J., Schiavi, F., Opocher, G., Boedeker, C. C., Tirosh, A., Castinetti, F., Ruf, J., et al. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0085 · Cited by 82
Niemann, S., Müller, U., Engelhardt, D., & Lohse, P. (2003) · Human Genetics · doi:10.1007/s00439-003-0938-0 · Cited by 82
“To date, only one alteration, a start codon mutation, has been identified in SDHC in a family with hereditary paraganglioma (Niemann and Müller 2000).”
InfluentialSelf-citationMolecular characterisation of a common SDHB deletion in paraganglioma patients
Cascón, A., Landa, I., López-Jiménez, E. A., Díez-Hernández, A., Buchta, M., Montero‐Conde, C., Leskelä, S., Leandro-Garcia, L. J., Letón, R., Rodríguez‐Antona, C., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.054965 · Cited by 82
Loss of SDHB Promotes Dysregulated Iron Homeostasis, Oxidative Stress, and Sensitivity to Ascorbate
Goncalves, J., Moog, S., Morin, A., Gentric, G., Müller, S., Morrell, A. P., Kľučková, K., Stewart, T. J., Andoniadou, C. L., Lussey‐Lepoutre, C., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2936 · Cited by 81
“Since the initial discovery of SDHD mutations in 2000 (1), all four SDHx genes have been demonstrated to act as tumor suppressor genes (2, 3, 4).”
BackgroundYeast Models of Human Mitochondrial Diseases
Barrientos, A. (2003) · IUBMB Life · doi:10.1002/tbmb.718540876 · Cited by 81
Malignant Paragangliomas Associated with Mutations in the Succinate Dehydrogenase D Gene
Havekes, B., Corssmit, E. P. M., Jansen, J. C., van der Mey, A. G. L., Vriends, A. H. J. T., & Romijn, J. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1993 · Cited by 81
Dannenberg, H., Dinjens, W. N. M., Abbou, M., van Urk, H., Pauw, B. K. H., Mouwen, D., Mooi, W. J., & de Krijger, R. R. (2002) · PubMed · Cited by 81
Tumours of familial origin in the head and neck
Suarez, C. M., Rodrigo, J. P., Ferlito, A., Cabanillas, R., Shaha, A. R., & Rinaldo, A. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2006.03.002 · Cited by 80
The Approach to the Patient with Paraganglioma
Neumann, H. P. H., & Eng, C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0496 · Cited by 79
Imaging of tumor glucose utilization with positron emission tomography
Bürkle, A., & Weber, W. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9151-x · Cited by 79
“Inherited or somatic mutations in SDHB, SDHC and SDHD have been shown to lead to the development of pheochromocytoma, whereas inherited mutations in FH can cause leiomyoma, leiomyosarcoma or renal-cell carcinoma [67–70].”
BackgroundSuccinate Dehydrogenase-deficient Tumors: Diagnostic Advances and Clinical Implications
Barletta, J. A., & Hornick, J. L. (2012) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31825c6bc6 · Cited by 79
Mitochondrial determinants of cancer health disparities
Choudhury, A. R., & Singh, K. K. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.001 · Cited by 78
Mutation of SDHB is a Cause of Hypoxia-Related High-Altitude Paraganglioma
Cerecer-Gil, N. Y., Figuera, L. E., Llamas, F. J., Lara, M., Escamilla, J. G., Ramos, R., Estrada, G., Hussain, A. K., Gaal, J., Korpershoek, E., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0637 · Cited by 71
Kytölä, S. I., Nord, B., Elder, E. E., Carling, T., Kjellman, M., Cedermark, B., Juhlin, C., Höög, A., Isola, J. J., & Larsson, C. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10081 · Cited by 78
“In addition, other subunits of the mitochondrial succinate dehydrogenase, SDHC at 1q21 and SDHB at 1p36, have been shown to be mutated in families with hereditary head and neck paraganglioma and familial pheochromocytoma (Niemann and Muller, 2000; Astuti et al., 2001b).”
Genetics of pheochromocytomas and paragangliomas
Opocher, G., & Schiavi, F. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.05.001 · Cited by 77
Pheochromocytoma and Paraganglioma
Pacák, K., & Wimalawansa, S. J. (2015) · Endocrine Practice · doi:10.4158/ep14481.ra · Cited by 77
Phaeochromocytoma: a catecholamine and oxidative stress disorder
Pacák, K. (2011) · Endocrine Regulations · doi:10.4149/endo_2011_02_65 · Cited by 76
The role of mitochondrial electron transport in tumorigenesis and metastasis
Tan, A. S., Baty, J. W., & Berridge, M. V. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.016 · Cited by 76
Jafri, M., Whitworth, J., Rattenberry, E., Vialard, L., Kilby, G., Kumar, A., Izatt, L., Lalloo, F. I., Brennan, P., Cook, J. A., et al. (2012) · Clinical Endocrinology · doi:10.1111/cen.12074 · Cited by 76
Proportion of Heritable Paraganglioma Cases and Associated Clinical Characteristics
Drovdlic, C. M., Myers, E. N., Peters, J. A., Baysal, B. E., Brackmann, D. E., Slattery, W. H., & Rubinstein, W. S. (2001) · The Laryngoscope · doi:10.1097/00005537-200110000-00029 · Cited by 76
“A third locus was implied by the presence of families that did not link to either the PGL1 or PGL2 region and was identified as the succinateubiquinone oxidoreductase subunit C (SDHC) gene located on chromosome 1q21.(9,10) SDHC and SDHD are both Presented in abstract form at the American Society of Human Genetics annu…”
BackgroundSuccinate dehydrogenase: Prospect for neurodegenerative diseases
Farshbaf, M. J., & Kiani‐Esfahani, A. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.12.002 · Cited by 75
Murakumo, Y., Jijiwa, M., Asai, N., Ichihara, M., & Takahashi, M. (2006) · Pituitary · doi:10.1007/s11102-006-0263-4 · Cited by 75
Hypoxia and Hypoxia Inducible Factors (HIF) as Important Regulators of Tumor Physiology
Acker, T., & Plate, K. H. (2004) · Cancer treatment and research · doi:10.1007/978-1-4419-8871-3_14 · Cited by 75
Enzymatic features of the glucose metabolism in tumor cells
Herling, A., König, M., Bulik, S., & Holzhütter, H. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08174.x · Cited by 74
Genomic imprinting and environment in hereditary paraganglioma
Baysal, B. E. (2004) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30018 · Cited by 74
“In contrast, mutations in SDHB and SDHC cause PGL following maternal [Niemann and Muller, 2000; Astuti et al., 2001; Niemann et al., 2003] and paternal [Baysal et al., 2002; Baysal et al., in press] transmissions.”
BackgroundInfluentialCleven, A. H. G., Suijker, J., Agrogiannis, G., Bruijn, I. H. B., Frizzell, N., Hoekstra, A. S., Wijers‐Koster, P. M., Cleton-Jansen, A., & Bovée, J. V. M. G. (2017) · Clinical Sarcoma Research · doi:10.1186/s13569-017-0074-6 · Cited by 73
Máximo, V., Lima, J. P., Soares, P., & Sobrinho-Simões, M. A. (2009) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-009-0766-2 · Cited by 73
“[4], other studies showed that also SDHB and SDHC, which encode two other subunits of SDH, are mutated in familial PGL and phaeochromocytomas [5, 6].”
ResultGastrointestinal stromal tumours: from KIT to succinate dehydrogenase
Doyle, L. A., & Hornick, J. L. (2013) · Histopathology · doi:10.1111/his.12302 · Cited by 72
Evolving concepts in pheochromocytoma and paraganglioma
Dahia, P. L. (2006) · Current Opinion in Oncology · doi:10.1097/01.cco.0000198017.45982.06 · Cited by 69
Mahdi, H., Mester, J. L., Nizialek, E. A., Ngeow, J. Y. Y., Michener, C. M., & Eng, C. (2014) · Cancer · doi:10.1002/cncr.29106 · Cited by 71
“Serous/clear cell 15 (5) 4 (11) Mucinous 1 (0.”
Gallardo, M. E., Moreno‐Loshuertos, R., López‐Menéndez, C., Casqueiro, M., Silva, J., Bonilla, F., de Córdoba, S. R., & Enríquez, J. A. (2006) · Human Mutation · doi:10.1002/humu.20338 · Cited by 72
“structural OXPHOS genes in cancer gained recently support with the demonstration that specific mutations in subunits C and D of complex II (SDHC; MIM] 602413 and SDHD; MIM] 602690) are responsible for hereditary paraganglioma (MIM]168000), and an interesting molecular link among the complex II deficiency and the promo…”
BackgroundHIF and fumarate hydratase in renal cancer
Sudarshan, S., Linehan, W. M., & Neckers, L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603547 · Cited by 71
“Despite possibly sharing a similar mechanism for tumorigenesis, HLRCC and HPGL represent two distinct syndromes with minimal overlap.”
BackgroundInfluentialSpecific mitochondrial DNA mutation in mice regulates diabetes and lymphoma development
Hashizume, O., Shimizu, A., Yokota, M., Sugiyama, A., Nakada, K., Miyoshi, H., Itami, M., Ohira, M., Nagase, H., Takenaga, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202367109 · Cited by 70
Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma
Kľučková, K., & Tennant, D. A. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2801-6 · Cited by 70
“…years, mutations in the other three SDH genes (A, B and C) and its assembly factor (SDHAF2) were also observed, adding considerable evidential weight to SDHx genes being critical tumour suppressors linked to PPGL (Astuti et al. 2001; Burnichon et al. 2010; Hao et al. 2009; Niemann and Muller 2000).”
BackgroundThe Genetic Basis of Pheochromocytoma
Gimm, O., Koch, C. A., Januszewicz, A., Opocher, G., & INeumann, H. P. H. (2003) · KARGER eBooks · doi:10.1159/000074657 · Cited by 70
Tran, Q. M., Rothery, R. A., Maklashina, E., Cecchini, G., & Weiner, J. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607476200 · Cited by 64
Succinate dehydrogenase (SDH) deficiency, Carney triad and the epigenome
Settas, N., Faucz, F. R., & Stratakis, C. A. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.07.018 · Cited by 70
“Germline mutations in SDHD, SDHB and SDHC genes, were identified in patients with hereditary paragangliomas and pheochromocytomas (Astuti et al., 2001; Baysal et al., 2000; Niemann and Muller, 2000) in the early 2000’s (Astuti et al.”
BackgroundYeap, P. M., Tobias, E. S., Mavraki, E., Fletcher, A. J., Bradshaw, N., Freel, E. M., Cooke, A., Murday, V. A., Davidson, H. R., Perry, C. G., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1244 · Cited by 69
Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes
Bauters, C., Vantyghem, M., Leteurtre, E., Odou, M., Mouton, C., Porchet, N., Wemeau, J.-L., Proye, C., & Pigny, P. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.6.e75 · Cited by 69
Hoerner, C. R., Chen, V. J., & Fan, A. C. (2019) · Kidney Cancer · doi:10.3233/kca-180043 · Cited by 68
Assembly of mitochondrial succinate dehydrogenase in human health and disease
Cao, K. J., Xu, J., Cao, W., Wang, X., Lv, W., Zeng, M., Zou, X., Liu, J., & Feng, Z. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.023 · Cited by 68
Signaling Pathways in Pheochromocytomas and Paragangliomas: Prospects for Future Therapies
Nölting, S., & Grossman, A. B. (2012) · Endocrine Pathology · doi:10.1007/s12022-012-9199-6 · Cited by 68
Genetic Testing for Pheochromocytoma
Karásek, D., Fryšák, Z., & Pacák, K. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0151-1 · Cited by 67
MANAGEMENT OF ENDOCRINE DISEASE: Clinical management of paragangliomas
Corssmit, E. P. M., & Romijn, J. A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0396 · Cited by 67
Precision medicine in pheochromocytoma and paraganglioma: current and future concepts
Björklund, P., Pacák, K., & Crona, J. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12507 · Cited by 67
Solid tumors associated with multiple endocrine neoplasias
Almeida, M. Q., & Stratakis, C. A. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.09.006 · Cited by 66
“Paraganglioma syndromes are caused by mutations in the SDH genes: paraganglioma syndrome type 1 (SDHD) [12], paraganglioma syndrome type 3 (SDHC ) [13], and paraganglioma syndrome type 4 (SDHB) [14].”
SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors
Italiano, A., Chen, C.-L., Sung, Y., Singer, S., DeMatteo, R. P., LaQuaglia, M. P., Besmer, P., Socci, N. D., & Antonescu, C. R. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-408 · Cited by 66
“However, this vision has been recently challenged by the finding that a significant proportion of familial and apparently sporadic paraganglioma and pheochromocytoma are related to germline somatic mutation of genes encoding proteins of SDH complex II [21-25].”
BackgroundSuccinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors
Belinsky, M. G., Rink, L., & von Mehren, M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00117 · Cited by 66
“Gastrointestinal stromal tumors are exceedingly rare in children and adolescents.”
BackgroundInfluentialMetabolic synthetic lethality in cancer therapy
Zecchini, V. R., & Frezza, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.12.003 · Cited by 66
RECENT ADVANCES IN THE GENETICS OF PHAEOCHROMOCYTOMA AND FUNCTIONAL PARAGANGLIOMA
Gimenez‐Roqueplo, A., Burnichon, N., Amar, L., Favier, J., Jeunemaître, X., & Plouin, P. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04881.x · Cited by 66
Clinical Features of Paraganglioma Syndromes
Boedeker, C. C., Neumann, H., Offergeld, C., Maier, W., Falcioni, M., Berlis, A., & Schipper, J. (2009) · Skull base · doi:10.1055/s-0028-1103123 · Cited by 65
“%) and jugulotympanic tumors (2 to 4%).25 There are no internationally defined criteria concerning the preoperative search for local and distant metastases or the extent of lymphadenectomy in the removal of HNP.”
BackgroundInfluential
Metadata
- Authors
- Niemann, S., & Müller, U.
- Affiliations
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- Müller, Ulrich
- ORCID
- Müller, Ulrich
- Venue
- Nature Genetics
- Published
- 2000-11
- Volume
- 26
- Issue
- 3
- Pages
- 268-270
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1528834211
- Cited by
- 875
- References
- 9
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 9 · 2023: 18 · 2022: 14 · 2021: 24 · 2020: 24 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 36 · 2015: 44 · 2014: 59 · 2013: 49 · 2012: 72
- FWCI
- 32.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- SDHC, nonchromaffin paraganglioma, autosomal dominant inheritance, familial paraganglioma, neural crest tumors, parasympathetic ganglia, penetrance
- MeSH terms
- Chromosomes, Human, Pair 1, DNA Mutational Analysis, Female, Genes, Dominant, Humans, Male, Membrane Proteins, Mitochondria, Molecular Sequence Data, Multienzyme Complexes, Neoplastic Syndromes, Hereditary, Oxidoreductases, Paraganglioma, Pedigree, Succinate Dehydrogenase, Mutagenesis, Site-Directed, DNA, Complementary, Protein Subunits, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.